The Passy-Muir Speaking Valve (PMV) is a one-way airflow valve designed for patients with a tracheostomy tube. It opens on inhalation to allow air into the lungs, then closes on exhalation, redirecting airflow upward through the vocal cords, pharynx, and mouth. This restored airflow pattern has profound implications not only for voice production but for swallowing safety — making it a critical piece of equipment in the dysphagia management of tracheostomised patients.
A standard tracheostomy tube creates an open column between the trachea and the outside air. During exhalation, air exits through the trach tube rather than flowing through the upper airway. This disrupts the normal subglottic air pressure that aids vocal cord closure and contributes to protective swallowing reflexes.
The PMV’s closed-position spring mechanism restores translaryngeal airflow on exhalation. Key physiological consequences:
Tracheostomised patients face several swallowing challenges not seen in the general dysphagia population:
PMV use addresses several of these issues simultaneously. Clinical evidence suggests that patients placed on a PMV trial show improvements in swallowing safety scores on instrumental assessments such as videofluoroscopic swallowing study (VFSS) and flexible endoscopic evaluation of swallowing (FEES).
Not all tracheostomised patients are appropriate PMV candidates. The following criteria should be met before trialling:
Inclusion indicators:
Key assessment step — cuff deflation trial: Before any PMV can be placed, the tracheostomy cuff must be deflated. Patients who cannot maintain oxygen saturation or respiratory rate during cuff deflation are not yet candidates for PMV.
| Contraindication | Reason |
|---|---|
| Inflated tracheostomy cuff during valve use | No expiratory airflow path — risk of asphyxiation |
| Severe upper airway obstruction | Cannot exhale around trach tube |
| Copious secretions risking valve occlusion | Valve may block |
| Severe respiratory compromise | Increased expiratory resistance may be unsafe |
| Unconscious or uncooperative patient | Cannot monitor response |
| Foam-cuffed tracheostomy tube | Cuff cannot be fully deflated |
Note: The PMV is designed for use only with the cuff deflated. This is non-negotiable and the most common cause of critical incidents involving the valve.
PMV placement is inherently a multidisciplinary procedure in most Hong Kong public hospitals and rehabilitation centres:
SLPs in Hong Kong working in the Hospital Authority system typically follow a standardised protocol for PMV introduction, often beginning with short supervised trials of 15–30 minutes.
Introduce the PMV gradually:
Where resources permit, swallowing function should be assessed instrumentally both with and without the PMV. Some patients show significantly better swallowing on FEES or VFSS with the valve in place, reinforcing the case for its continued use. Others show little difference, which informs the clinical decision about how much emphasis to place on PMV in the overall rehabilitation plan.
PMV is available through:
The Passy-Muir Speaking Valve is far more than a voice restoration device. By restoring translaryngeal airflow, it directly supports the sensory and motor components of safe swallowing in tracheostomised patients. Careful patient selection, mandatory cuff deflation, multidisciplinary coordination, and gradual introduction are the cornerstones of safe and effective PMV use. For speech-language pathologists managing dysphagia in this population, the PMV is often an indispensable clinical tool.